Abstract
PET (Positron-Emission Tomography) has a unique feature that is visualized “metabolic activities” of cell, or tissue. Malignant tumors including esophageal cancers usually show hypermetabolism of glucose to be depicted clearly by using FDG-PET.
The role of FDG-PET for esophageal cancer includes staging (detecting lymph node, distant metastases), response assessment for chemo (radiation) therapy, and early detection of recurrence (surveillance). FDG-PET/CT is a very useful imaging modalities not for all, but for selected esophageal cancer patients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kato H, Miyazaki T, Nakajima M, et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer. 2005;103:148–56.
NCCN guidelines Ver. 1. Esophageal and esophagogastric junction cancers. National Comprehensive Cancer Network®; 2019. https://www.nccn.org/
Miyazaki T, Sohda M, Higuchi T, et al. Effectiveness of FDG-PET in screening of synchronous cancer of other organs in patients with esophageal cancer. Anticancer Res. 2014;34(1):283–7.
van Westreenen HL, Westerterp M, Bossuyt PM, et al. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol. 2004;22(18):3805–12.
Greally M, Chou JF, Molena D, et al. Positron-emission tomography scan-directed Chemoradiation for esophageal squamous cell carcinoma: no benefit for a change in chemotherapy in positron-emission tomography nonresponders. J Thorac Oncol. 2019;14(3):540–6.
Tandberg DJ, Cui Y, Rushing CN, et al. Intratreatment response assessment with 18F-FDG PET: correlation of Semiquantitative PET features with pathologic response of esophageal cancer to Neoadjuvant Chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2018;102(4):1002–7.
Choi JY, Lee KH, Shim YM, et al. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. J Nucl Med. 2000;41(5):808–15.
Imaging diagnosis guideline. Japan radiological society. Tokyo, Japan: Kanehara shuppan; 2016.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Murakami, K. (2020). Diagnostic Imaging: PET/CT(PET). In: Ando, N. (eds) Esophageal Squamous Cell Carcinoma. Springer, Singapore. https://doi.org/10.1007/978-981-15-4190-2_4
Download citation
DOI: https://doi.org/10.1007/978-981-15-4190-2_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-4189-6
Online ISBN: 978-981-15-4190-2
eBook Packages: MedicineMedicine (R0)